Welcome to the New Era of Viral Therapy
Calling all vaccine developers, cell therapy experts, virologists and immunologists… are you working to develop long-term, curative treatment for infectious disease?
If yes, you are in the right place. The Cell-Mediated Therapies for Infectious Disease Summit is the first and only meeting dedicated to driving a potent T-cell mediated attack against infectious disease epitopes, to develop long lasting immunity against SARS-CoV-2, HIV and EBV.
Join pioneering experts from pharma, biotech and academia to:
Gain insight into the strategic decision making of Gilead, Merck and AgenTus. Ask your questions to uncover why they have targeted specific indications, why T-cell immunity has become a priority and their future plans for portfolio growth.
Strike a safe balance with the immune system, managing the tipping point between an overactive immune system Vs. a strong immune response.
Compare bioinformatics tools to classify immunogenic targets with TScan Therapeutics and QIMR Berghofer and understand how molecular signatures of T cell drug products can impact clinical response.
Uncover the two faces of EBV, lytic and latent, and assess current CAR-T and checkpoint inhibitor therapies to overcome EBV’s immune escape with Hannover Medical School and Children’s National Medical Center.